in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/fine chemicals roundup—12 February
7:43 AM MST | February 12, 2013 | Deepti Ramesh
Teva’s API business reports rise in sales The active pharmaceutical ingredient (API) business of Teva Pharmaceutical (Petaḥ Tiqwa, Israel), recorded a 2.5% increase in sales in the fourth quarter of 2012 compared with the year-ago period, to $202 million. Teva has the largest API business in the world in terms of sales. For the full-year 2012, Teva's API business reported a 6.5% rise in sales compared with 2011, to $796 million. Earnings figures for the API business were not disclosed. Albemarle announces expansion of fine chemicals site in Pennsylvania...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee